{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:43:29Z","timestamp":1777419809172,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1016\/s0161-813x(02)00060-8","type":"journal-article","created":{"date-parts":[[2002,10,17]],"date-time":"2002-10-17T01:46:23Z","timestamp":1034819183000},"page":"569-580","source":"Crossref","is-referenced-by-count":22,"title":["Acute Mitochondrial and Chronic Toxicological Effects of 1-Methyl-4-Phenylpyridinium in Human Neuroblastoma Cells"],"prefix":"10.1016","volume":"23","author":[{"given":"Stacy E.","family":"Stephans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.Timothy","family":"Greenamyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0161-813X(02)00060-8_BIB1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ana.104","article-title":"Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson\u2019s disease","volume":"49","author":"Blandini","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB2","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1006\/bbrc.1999.0487","article-title":"Glucose protection from MPP+-induced apoptosis depends on mitochondrial membrane potential and ATP synthase","volume":"257","author":"Chalmers-Redman","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-291X(84)91293-2","article-title":"Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase","volume":"120","author":"Chiba","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB5","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1046\/j.1471-4159.2001.00096.x","article-title":"Dopaminergic cell death induced by MPP+, oxidant and specific neurotoxicants shares the common molecular mechanism","volume":"76","author":"Chun","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB6","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1523\/JNEUROSCI.15-03-01714.1995","article-title":"The dopamine transporter: immunochemical characterization and localization in brain","volume":"15","author":"Ciliax","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB7","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1471-4159.1992.tb09789.x","article-title":"Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement","volume":"58","author":"Cleeter","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/bj2880439","article-title":"Uptake and accumulation of 1-methyl-4-phenylpyridinium by rat liver mitochondria measured using an ion-selective electrode","volume":"288","author":"Davey","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB9","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1046\/j.1471-4159.1997.69031322.x","article-title":"Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter","volume":"69","author":"Gainetdinov","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.119.3.493","article-title":"Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation","volume":"119","author":"Gavrieli","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB11","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nm0996-1017","article-title":"Inhibition of neuronal nitric oxide synthase prevents MPTP-induced Parkinsonism in baboons","volume":"2","author":"Hantraye","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB12","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/S0161-813X(02)00060-8_BIB13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/311467a0","article-title":"Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors","volume":"311","author":"Heikkila","year":"1984","journal-title":"Nature"},{"key":"10.1016\/S0161-813X(02)00060-8_BIB14","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1523\/JNEUROSCI.16-12-03807.1996","article-title":"[3H]dihydrorotenone binding to NADH: ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study","volume":"16","author":"Higgins","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB15","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0021-9258(19)86052-0","article-title":"Determination of the mitochondrial protonmotive force in isolated hepatocytes","volume":"255","author":"Hoek","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","article-title":"Nitric oxide synthase and neuronal vulnerability in Parkinson\u2019s disease","volume":"72","author":"Hunot","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/S0161-813X(02)00060-8_BIB17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-4274(98)00231-8","article-title":"Reduced levels of catalase activity potentiate MPP+-induced toxicity: comparison between MN9D cells and CHO cells","volume":"11","author":"Hussain","year":"1999","journal-title":"Toxicol. Lett."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB18","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ana.410320120","article-title":"Parkinsonism-inducing neurotoxin MPP+: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA","volume":"32","author":"Kitayama","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0006-291X(90)91442-U","article-title":"Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone","volume":"169","author":"Krueger","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/S0161-813X(02)00060-8_BIB22","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1523\/JNEUROSCI.19-04-01284.1999","article-title":"Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons","volume":"19","author":"Lotharius","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/311464a0","article-title":"Intraneuronal generation of a pyridinium metabolite may cause drug-induced Parkinsonism","volume":"311","author":"Markey","year":"1984","journal-title":"Nature"},{"key":"10.1016\/S0161-813X(02)00060-8_BIB24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(85)90201-8","article-title":"Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP","volume":"116","author":"Melamed","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ana.410410417","article-title":"Immunochemical analysis of dopamine transporter protein in Parkinson\u2019s disease","volume":"41","author":"Miller","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB26","first-page":"631","article-title":"Heptachlor alters expression and function of dopamine transporters","volume":"20","author":"Miller","year":"1999","journal-title":"Neurotoxicology"},{"key":"10.1016\/S0161-813X(02)00060-8_BIB27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0165-6147(99)01379-6","article-title":"Dopamine transporters and neuronal injury","volume":"20","author":"Miller","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1124\/mol.58.2.271","article-title":"The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited","volume":"58","author":"Nakamura","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-4173(82)90013-1","article-title":"Mitochondrial calcium transport","volume":"683","author":"Nicholls","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/S0161-813X(02)00060-8_BIB30","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.bb.23.060194.000511","article-title":"The light-addressable potentiometric sensor: principles and biological applications","volume":"23","author":"Owicki","year":"1994","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB32","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1523\/JNEUROSCI.13-10-04246.1993","article-title":"Dopamine transporter expression confers cytotoxicity to low doses of the Parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium","volume":"13","author":"Pifl","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1523\/JNEUROSCI.12-03-00773.1992","article-title":"Effects of excitotoxin exposure on metabolic rate of primary hippocampal cultures: application of silicon microphysiometry to neurobiology","volume":"12","author":"Raley-Susman","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-291X(86)90972-1","article-title":"Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic Parkinsonism","volume":"135","author":"Ramsay","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB35","first-page":"1400","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured neurons: relationship to the dopamine uptake system and inhibition of mitochondrial respiration","volume":"260","author":"Saporito","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB36","first-page":"241","article-title":"An in vitro model of Parkinson\u2019s disease: chronic complex I inhibition","volume":"26","author":"Sherer","year":"2000","journal-title":"Soc. Neurosci. Abst."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB37","first-page":"359","article-title":"Dopamine transporter mRNA: dense expression in ventral midbrain neurons","volume":"13","author":"Shimada","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB38","first-page":"192","article-title":"The reaction sites of rotenone and ubiquinone with mitochondrial NADH dehydrogenase","volume":"118","author":"Singer","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/S0161-813X(02)00060-8_BIB39","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1097\/00001756-199412000-00048","article-title":"Reduction of MPP+-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase","volume":"5","author":"Smith","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/S0161-813X(02)00060-8_BIB40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/excr.1999.4504","article-title":"MPP+ inhibits proliferation of PC12 cells by a p21(WAF1\/Cip1)-dependent pathway and induces cell death in cells lacking p21(WAF1\/Cip1)","volume":"250","author":"Soldner","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB41","first-page":"341","article-title":"Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells","volume":"18","author":"Song","year":"1997","journal-title":"Neurotoxicology"},{"key":"10.1016\/S0161-813X(02)00060-8_BIB42","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/j.1471-4159.1992.tb10080.x","article-title":"1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism","volume":"58","author":"Storey","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB43","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/349414a0","article-title":"Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-d-aspartate antagonists","volume":"349","author":"Turski","year":"1991","journal-title":"Nature"},{"key":"10.1016\/S0161-813X(02)00060-8_BIB44","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ana.410430503","article-title":"Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson\u2019s disease","volume":"43","author":"Uhl","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB45","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1523\/JNEUROSCI.21-24-09519.2001","article-title":"Caspase-9 activation results in downstream caspase-8 activation and Bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson\u2019s disease","volume":"21","author":"Viswanath","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB46","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1471-4159.1986.tb01768.x","article-title":"Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium","volume":"46","author":"Vyas","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/S0161-813X(02)00060-8_BIB47","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1471-4159.1992.tb09429.x","article-title":"MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in primates","volume":"59","author":"Zuddas","year":"1992","journal-title":"J. Neurochem."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X02000608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X02000608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T05:47:05Z","timestamp":1622267225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X02000608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":47,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0161813X02000608"],"URL":"https:\/\/doi.org\/10.1016\/s0161-813x(02)00060-8","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}